Public health plan for the pharmaceutical treatment of hepatitis c

Hdl Handle:
http://hdl.handle.net/10147/575348
Title:
Public health plan for the pharmaceutical treatment of hepatitis c
Authors:
Department of Health (DoH)
Citation:
Department of Health,
Publisher:
Department of Health (DoH)
Issue Date:
Dec-2014
URI:
http://hdl.handle.net/10147/575348
Item Type:
Report
Language:
en
Description:
The role of this advisory group was to advise on the feasibility of a multiannual public health treatment plan for patients with hepatitis C infection based on clinical prioritisation criteria for identification of patients for each treatment phase.The Advisory group included patient advocates, clinicians, the National Centre for Pharmaco-economics (NCPE),HIQA,the HSE and officials from the Department of Health and is chaired by the CMO’s office After reviewing the evidence on clinical and cost effectiveness and the budget impact of the new drug regimens, the Group advised on the development of a treatment strategy. This treatment strategy’s implementation will over the next few years aim to increase the number of people with hepatitis C infection being treated effectively with complete clearance of the virus and reduce the numbers of people in the community with hepatitis C. Theimplementation of the treatment strategy is an important component in ultimately working towards eradication of hepatitis C in the Irish population.
Keywords:
HEALTH SERVICES AND THEIR MANAGEMENT; HEPATITIS C

Full metadata record

DC FieldValue Language
dc.contributor.authorDepartment of Health (DoH)en
dc.date.accessioned2015-08-20T10:51:53Zen
dc.date.available2015-08-20T10:51:53Zen
dc.date.issued2014-12en
dc.identifier.citationDepartment of Health,en
dc.identifier.urihttp://hdl.handle.net/10147/575348en
dc.descriptionThe role of this advisory group was to advise on the feasibility of a multiannual public health treatment plan for patients with hepatitis C infection based on clinical prioritisation criteria for identification of patients for each treatment phase.The Advisory group included patient advocates, clinicians, the National Centre for Pharmaco-economics (NCPE),HIQA,the HSE and officials from the Department of Health and is chaired by the CMO’s office After reviewing the evidence on clinical and cost effectiveness and the budget impact of the new drug regimens, the Group advised on the development of a treatment strategy. This treatment strategy’s implementation will over the next few years aim to increase the number of people with hepatitis C infection being treated effectively with complete clearance of the virus and reduce the numbers of people in the community with hepatitis C. Theimplementation of the treatment strategy is an important component in ultimately working towards eradication of hepatitis C in the Irish population.en
dc.language.isoenen
dc.publisherDepartment of Health (DoH)en
dc.subjectHEALTH SERVICES AND THEIR MANAGEMENTen
dc.subjectHEPATITIS Cen
dc.titlePublic health plan for the pharmaceutical treatment of hepatitis cen
dc.typeReporten
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.